# Phase I Study of KPT330 in Asian Patients

> **NCT02078349** · PHASE1 · COMPLETED · sponsor: **National University Hospital, Singapore** · enrollment: 120 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** KPT-330

## Key facts

- **NCT ID:** NCT02078349
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2020-03-20
- **Final completion:** 2020-03-20
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2020-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02078349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02078349, "Phase I Study of KPT330 in Asian Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02078349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*